Swiss National Bank reduced its stake in shares of STERIS plc (NYSE:STE – Free Report) by 2.6% during the fourth quarter, Holdings Channel reports. The institutional investor owned 308,960 shares of the medical equipment provider’s stock after selling 8,400 shares during the period. Swiss National Bank’s holdings in STERIS were worth $67,925,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds also recently made changes to their positions in STE. Millburn Ridgefield Corp bought a new stake in STERIS during the 3rd quarter worth approximately $25,000. Catalyst Capital Advisors LLC purchased a new stake in shares of STERIS in the third quarter worth $25,000. Global Wealth Management Investment Advisory Inc. bought a new stake in shares of STERIS during the 3rd quarter valued at $49,000. NBC Securities Inc. purchased a new position in shares of STERIS during the 3rd quarter valued at $50,000. Finally, Exchange Traded Concepts LLC bought a new position in STERIS in the 3rd quarter worth $54,000. 94.69% of the stock is currently owned by institutional investors.
STERIS Stock Performance
NYSE STE opened at $207.82 on Monday. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.43 and a quick ratio of 1.49. STERIS plc has a 1-year low of $185.22 and a 1-year high of $254.00. The business has a 50 day simple moving average of $218.46 and a two-hundred day simple moving average of $216.09. The stock has a market capitalization of $20.53 billion, a PE ratio of 36.40 and a beta of 0.81.
STERIS Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, June 26th. Stockholders of record on Wednesday, June 12th will be issued a $0.52 dividend. The ex-dividend date of this dividend is Wednesday, June 12th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 1.00%. STERIS’s dividend payout ratio (DPR) is presently 36.43%.
Wall Street Analyst Weigh In
STE has been the subject of a number of analyst reports. StockNews.com cut STERIS from a “buy” rating to a “hold” rating in a report on Friday. JMP Securities reissued a “market outperform” rating and set a $265.00 target price on shares of STERIS in a research note on Thursday, February 8th. KeyCorp initiated coverage on STERIS in a research note on Tuesday, February 6th. They issued an “overweight” rating and a $253.00 price target for the company. Needham & Company LLC reaffirmed a “hold” rating on shares of STERIS in a report on Friday, April 12th. Finally, TheStreet raised shares of STERIS from a “c+” rating to a “b” rating in a report on Wednesday, February 7th. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, STERIS has a consensus rating of “Hold” and a consensus target price of $239.60.
Check Out Our Latest Stock Report on STERIS
About STERIS
STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.
Read More
- Five stocks we like better than STERIS
- 5 discounted opportunities for dividend growth investors
- Brinker International Heats Up on Spicy Earnings Beat and Raise
- The How and Why of Investing in Gold Stocks
- Eli Lilly Gains on the GLP-1 Weight Loss Phenomenon
- What is a Low P/E Ratio and What Does it Tell Investors?
- Pfizer Finds a Foothold After a Solid Q1 2024 Earnings Report
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STERIS plc (NYSE:STE – Free Report).
Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.